Cell Signaling Technology

Phospho-WNK1 (Thr60) Antibody

#4946 · $362

100
Citing papers
7.6k
Combined citations
Supplier page Find this product

Research areas

Cell death mechanisms and regulation10Cancer-related Molecular Pathways7RNA modifications and cancer7PI3K/AKT/mTOR signaling in cancer6NF-κB Signaling Pathways6Immune Cell Function and Interaction5Chronic Myeloid Leukemia Treatments5Mitochondrial Function and Pathology5

Papers citing this product

1
Microbiome-Derived Tryptophan Metabolites and Their Aryl Hydrocarbon Receptor-Dependent Agonist and Antagonist Activities
Molecular Pharmacology·2014·337 cit.·DOI
2
Targeting SWI/SNF ATPases in enhancer-addicted prostate cancer
Nature·2021·311 cit.·DOI
3
MicroRNA-155 Is Required for Effector CD8+ T Cell Responses to Virus Infection and Cancer
Immunity·2013·305 cit.·DOI
4
The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancer
Nature Medicine·2021·253 cit.·DOI
5
Evidence for a TCR Affinity Threshold Delimiting Maximal CD8 T Cell Function
The Journal of Immunology·2010·223 cit.·DOI
6
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
Nature Communications·2020·206 cit.·DOI
7
Translation Initiation Factor eIF4G-1 Binds to eIF3 through the eIF3e Subunit
Journal of Biological Chemistry·2006·170 cit.·DOI
8
MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
Cell Reports·2015·153 cit.·DOI
9
WNT7B Promotes Bone Formation in part through mTORC1
PLoS Genetics·2014·148 cit.·DOI
10
Position of eukaryotic initiation factor eIF1 on the 40S ribosomal subunit determined by directed hydroxyl radical probing
Genes & Development·2003·140 cit.·DOI
Phospho-WNK1 (Thr60) Antibody — Evidence — PubIndex